Compugen Stock

Compugen EBIT CAGR 5Y

EBIT CAGR (5 Year) of Compugen (CGEN) as of Aug 14, 2026.

EBIT CAGR 5Y

0.00

Last updated:

EBIT CAGR (5 Year) of Compugen is 2026 0.00 . EBIT CAGR (5 Year) of Compugen was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Compugen since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Compugen historically and in real time.

Access this data via the Eulerpool API

Growth — Compugen

All Key Metrics — Compugen